Filter
431
Filtered Results: 431
Text search:
COVID-19
and
hypertension
Featured
Recommendations
57
New Publications
8
Language
Document type
Guidelines
154
Studies & Reports
142
Manuals
36
Strategic & Response Plan
36
Fact sheets
31
Situation Updates
9
No document type
9
Training Material
7
Infographics
5
Brochures
1
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
31
Global
25
South Africa
20
India
16
Africa
11
Western and Central Europe
10
Brazil
10
Ecuador
10
Colombia
8
Peru
8
Ukraine
7
West and Central Africa
7
South–East Asia Region
7
Chile
6
Bolivia
6
Kenya
5
Ghana
5
Nigeria
5
Eastern Europe and Central Asia
5
East and Southern Africa
5
Argentina
5
El Salvador
4
Syria
4
Philippines
4
Mozambique
4
Congo, Democratic Republic of
4
Middle East and North Africa
4
Spain
4
Ethiopia
4
Mexico
3
Sierra Leone
3
Venezuela
3
Germany
3
North America
3
Uganda
3
Russia
3
South Sudan
3
China
2
Niger
2
Zimbabwe
2
Western Pacific Region
2
Paraguay
2
France
2
Bangladesh
2
Vietnam
2
Eastern Europe
2
Honduras
2
Angola
2
Zambia
2
Iraq
2
Pakistan
2
Nepal
1
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Togo
1
Rwanda
1
Laos
1
Senegal
1
Afghanistan
1
Malawi
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Saudi Arabia
1
Mauritius
1
United Kingdom
1
Portugal
1
Nicaragua
1
Moldova
1
Sudan
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Chad
1
Somalia
1
Liberia
1
Eswatini/ Swaziland
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
203
Public Health
40
Clinical Guidelines
31
Women & Child Health
16
Capacity Building
9
Key Resources
7
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
246
NCDs
31
HIV
16
Caregiver
16
Global Health Education
13
Planetary Health
12
Conflict
9
TB
8
Mental Health
7
Refugee
7
Pharmacy
7
NTDs
4
Rapid Response
2
Natural Hazards
2
Health Financing Toolbox
2
Disability
1
AMR
1
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
7 April 2021
The holy month of Ramadan (mid-April to mid-May 2021) is marked by social and religious gatherings. Because of the ongoing COVID-19 pandemic, it is imperative to observe the holiday with caution and care. This document provides up-to-date public health advice that can be applied across...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
13 July 2021. Eid al Adha is a festival during which Muslim families and friends unite to pray together and give alms, especially in the form of sacrificed animal meat. In light of the COVID-19 pandemic, this document highlights public health advice for social gatherings and religious practices that...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)
Nigeria reported its first case of COVID-19 at the end of February 2020 and subsequently experienced
four waves, with peaks in June 2020 and January, August and December 2021. The COVID-19 pandemic
severely impacted the economy of Nigeria and caused disruption of health services nationwide. During...
Oxfam’s report found that Covid-19 has the potential to increase economic inequality in almost every country at once, the first time this has happened since records began over a century ago. It sets out how a rigged economy is enabling a super-rich elite to amass wealth in the middle of the worst ...
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemicINTERIM GUIDANCE5 February2021
The Community needs, perceptions and demand: community assessment toolcan be used by countries to conduct a rapid pulse survey of community health needs and perceptio...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
The "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2021 Global Survey" by WHO examines the global state of readiness and infrastructure for managing noncommunicable diseases (NCDs) across countries. Based on the 2021 survey, it analyzes nationa...
The WHO Health Emergencies Programme is currently monitoring 118 events in the region. This week’s main articles cover the following events:
Coronavirus disease 2019 (COVID-19) in Togo
Measles in Chad
Ebola virus disease (EVD) in Équateur Province, Democratic Republic of the Congo.
Thefirst report on Latin America and the Carribean presents key indicators on health and health systems in 33 Latin America and the Caribbean countries. . Analysis is based on the latest comparable data across almost 100 indicators including equity, health status, determinants of health, health car...
WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary
recommended
A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health service...
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ...
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
